Edgewise Therapeutics (EWTX) return on invested capital (ROIC)

Return on invested capital · fiscal 2023
-1544.0%

Only 1 fiscal year of return on invested capital is on record here for Edgewise Therapeutics (EWTX); a history needs at least 3. Figures as of 18 Nov 2026, 01:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2023
-1544.0%
Fiscal years on record
12023–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of return on invested capital needs at least 3 fiscal years; one is on record here for Edgewise Therapeutics. Nothing is estimated to fill the gap. What is on record is in the table below.

Edgewise Therapeutics return on invested capital (ROIC), year by year

Edgewise Therapeutics (EWTX) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
2023-1544.0%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Edgewise Therapeutics and comparable companies
CompanyReturn on invested capitalFiscal year
Concentra Group Holdings Parent CON10.7%2025
Merit Medical Systems MMSI7.1%2025
Edgewise Therapeutics EWTX-1544.0%2023
LivaNova LIVN15.8%2025
Dianthus Therapeutics DNTH-155.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics return on invested capital (ROIC): questions and answers

How is Edgewise Therapeutics's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/EWTX/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.